+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzymes for Drug Synthesis Market - Global Forecast 2026-2032- Product Image
Enzymes for Drug Synthesis Market - Global Forecast 2026-2032- Product Image
New

Enzymes for Drug Synthesis Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6121950
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The enzymes for drug synthesis market is experiencing significant momentum, driven by modern enzymatic technologies and shifting global supply dynamics. Advanced enzyme engineering, computational platforms, and evolving regulatory landscapes are accelerating adoption in research and manufacturing workflows.

Market Snapshot: Enzymes for Drug Synthesis

The Enzymes for Drug Synthesis Market grew from USD 7.04 billion in 2025 to USD 7.37 billion in 2026. It is expected to continue growing at a CAGR of 5.25%, reaching USD 10.08 billion by 2032. This growth reflects increased integration of biocatalysis across pharmaceutical research, scale-up, and production processes.

Scope & Segmentation of the Enzymes for Drug Synthesis Market

  • Enzyme Types: Hydrolases (including esterase, glycosidase, lipase, protease families such as aspartic, cysteine, metalloprotease, serine protease), Oxidoreductases (dehydrogenase, oxidase, oxygenase, reductase), Transferases (aminotransferase, glycosyltransferase, methyltransferase, phosphotransferase), as well as isomerases, ligases, and lyases.
  • Applications: Biocatalysis, chiral resolution, fermentation, and precursor synthesis, each shaping enzyme selection and performance priorities.
  • Source Origins: Animal, microbial, plant, and recombinant platforms, encompassing E Coli, fungal, and yeast expression systems for scalability and rapid optimization.
  • Process Types: Free enzyme and immobilized enzyme formats, including carrier-bound and cross-linked immobilization strategies to improve reuse and efficiency.
  • Product Forms: Liquid and solid formulations, influencing storage, handling, and dosing characteristics for end-users.
  • End Users: Academic institutes, biotech firms, contract research organizations, and pharmaceutical manufacturers—each with distinct quality, compliance, and service requirements.
  • Regions: Americas (established R&D and contract manufacturing networks), Europe/Middle East/Africa (advanced biotech hubs, regulatory diversity), Asia-Pacific (expanding manufacturing capacity, enzyme engineering sophistication).
  • Technologies: Enzyme engineering, directed evolution, computational protein design, immobilization methods, recombinant expression systems, and process intensification including continuous flow integrations.

Key Takeaways for Senior Decision-Makers

  • Enzyme-enabled synthesis now bridges R&D and large-scale manufacturing, providing enhanced control over process selectivity and sustainability.
  • Widespread adoption of computational design and machine learning supports tailored enzyme development, shortening project timelines and supporting rapid route validation.
  • Strategic supply chain management is essential as global trade and policy shifts introduce new risks, making supplier diversification and localized capabilities increasingly important.
  • Successful organizations are investing in modular expression, advanced immobilization, and flexible manufacturing infrastructures to adapt quickly to new technical and regulatory requirements.
  • Collaborations and partnerships enable faster adoption by providing integrated solutions spanning enzyme sourcing, technical optimization, regulatory support, and commercial scale-up.
  • Regional nuances in sustainability, process innovation, and regulatory guidance are shaping sourcing, deployment, and long-term strategic positioning.

Tariff Impact on Enzymes for Drug Synthesis Supply Chains

Recent tariff introductions have directly influenced sourcing strategies and cost structures across enzyme supply chains. Procurement teams are rebalancing global versus regional purchasing, pursuing nearshoring, and investing in local expression capacity to minimize exposure to international duties. New contractual frameworks, such as extended supply agreements and risk-sharing models, are being established to ensure reliable access and cost management. This evolving landscape prioritizes inventory resilience, vertical integration, and robust forecasting to reduce potential disruption from policy changes.

Methodology & Data Sources

This report is grounded in a mixed-methods approach. It draws on structured executive interviews with senior R&D, procurement, and manufacturing professionals across biopharma and enzyme suppliers. Secondary sources, including patent analysis, peer-reviewed publications, and technical white papers, validated market and technology trends. Scenario analysis and expert panel cross-validation were applied to ensure actionable reliability.

Why This Report Matters

  • Provides actionable insights for executives seeking to future-proof sourcing, technology, and manufacturing strategies in enzyme-enabled drug synthesis.
  • Highlights critical interdependencies between technology choice, operational resilience, and supply chain agility essential for sustaining competitiveness.
  • Supports strategic alignment by mapping technical advances, evolving policy impacts, and regional strengths across the global market.

Conclusion

As enzyme-enabled drug synthesis matures, organizations that integrate robust technical platforms, strategic sourcing, and agile operations will capture sustained value. Data-driven decision-making and cross-disciplinary partnerships will be central to leveraging both scientific and commercial advances.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Enzymes for Drug Synthesis Market, by Enzyme Type
8.1. Hydrolase
8.1.1. Esterase
8.1.2. Glycosidase
8.1.3. Lipase
8.1.4. Protease
8.1.4.1. Aspartic Protease
8.1.4.2. Cysteine Protease
8.1.4.3. Metalloprotease
8.1.4.4. Serine Protease
8.2. Isomerase
8.3. Ligase
8.4. Lyase
8.5. Oxidoreductase
8.5.1. Dehydrogenase
8.5.2. Oxidase
8.5.3. Oxygenase
8.5.4. Reductase
8.6. Transferase
8.6.1. Aminotransferase
8.6.2. Glycosyltransferase
8.6.3. Methyltransferase
8.6.4. Phosphotransferase
9. Enzymes for Drug Synthesis Market, by Source
9.1. Animal
9.2. Microbial
9.3. Plant
9.4. Recombinant
9.4.1. E Coli Expression Systems
9.4.2. Fungal Expression Systems
9.4.3. Yeast Expression Systems
10. Enzymes for Drug Synthesis Market, by Process Type
10.1. Free Enzyme
10.2. Immobilized Enzyme
10.2.1. Carrier Bound
10.2.2. Cross Linked
11. Enzymes for Drug Synthesis Market, by Product Form
11.1. Liquid Form
11.2. Solid Form
12. Enzymes for Drug Synthesis Market, by Application
12.1. Biocatalysis
12.2. Chiral Resolution
12.3. Fermentation
12.4. Precursor Synthesis
13. Enzymes for Drug Synthesis Market, by End User
13.1. Academic Institutes
13.2. Biotechnology Companies
13.3. Contract Research Organizations
13.4. Pharmaceutical Companies
14. Enzymes for Drug Synthesis Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Enzymes for Drug Synthesis Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Enzymes for Drug Synthesis Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Enzymes for Drug Synthesis Market
18. China Enzymes for Drug Synthesis Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AB Enzymes GmbH
19.6. ALLOYZMES Pte Ltd.
19.7. Amano Enzyme Inc.
19.8. BASF SE
19.9. Biomatter Inc.
19.10. Codexis, Inc.
19.11. DuPont de Nemours, Inc.
19.12. Evonik Industries AG
19.13. GenScript Biotech Corporation
19.14. Lonza Group AG
19.15. Novozymes A/S
19.16. Promega Corporation
19.17. Royal DSM N.V.
19.18. Takara Bio Inc.
List of Figures
FIGURE 1. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ESTERASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ESTERASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ESTERASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSIDASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSIDASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSIDASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIPASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIPASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIPASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ASPARTIC PROTEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ASPARTIC PROTEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ASPARTIC PROTEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CYSTEINE PROTEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CYSTEINE PROTEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CYSTEINE PROTEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METALLOPROTEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METALLOPROTEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METALLOPROTEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SERINE PROTEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SERINE PROTEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SERINE PROTEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ISOMERASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ISOMERASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ISOMERASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIGASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIGASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIGASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LYASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LYASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LYASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY DEHYDROGENASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY DEHYDROGENASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY DEHYDROGENASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXYGENASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXYGENASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXYGENASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REDUCTASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REDUCTASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REDUCTASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY AMINOTRANSFERASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY AMINOTRANSFERASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY AMINOTRANSFERASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSYLTRANSFERASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSYLTRANSFERASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GLYCOSYLTRANSFERASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METHYLTRANSFERASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METHYLTRANSFERASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY METHYLTRANSFERASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHOSPHOTRANSFERASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHOSPHOTRANSFERASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHOSPHOTRANSFERASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ANIMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY MICROBIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY E COLI EXPRESSION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY E COLI EXPRESSION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY E COLI EXPRESSION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FUNGAL EXPRESSION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FUNGAL EXPRESSION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FUNGAL EXPRESSION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FREE ENZYME, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FREE ENZYME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FREE ENZYME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CARRIER BOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CARRIER BOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CARRIER BOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CROSS LINKED, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CROSS LINKED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CROSS LINKED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIQUID FORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY LIQUID FORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOLID FORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOLID FORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOLID FORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOCATALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOCATALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOCATALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CHIRAL RESOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CHIRAL RESOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CHIRAL RESOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FERMENTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY FERMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRECURSOR SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRECURSOR SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRECURSOR SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 198. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 199. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 200. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 201. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 202. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 203. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 204. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 205. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 206. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 207. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. EUROPE ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 224. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 225. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 226. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 227. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 228. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 229. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 230. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 231. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 232. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 233. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. AFRICA ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 251. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 252. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 253. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 254. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 255. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 256. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 257. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 258. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 259. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 260. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 261. ASEAN ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 262. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 263. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 264. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 265. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 266. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 267. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 268. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 269. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 270. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 271. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 272. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 273. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. GCC ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 290. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 291. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 292. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 293. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 294. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 295. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 296. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 297. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 298. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 299. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 300. BRICS ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 301. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 302. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY ENZYME TYPE, 2018-2032 (USD MILLION)
TABLE 303. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY HYDROLASE, 2018-2032 (USD MILLION)
TABLE 304. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROTEASE, 2018-2032 (USD MILLION)
TABLE 305. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY OXIDOREDUCTASE, 2018-2032 (USD MILLION)
TABLE 306. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY TRANSFERASE, 2018-2032 (USD MILLION)
TABLE 307. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 308. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY RECOMBINANT, 2018-2032 (USD MILLION)
TABLE 309. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 310. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY IMMOBILIZED ENZYME, 2018-2032 (USD MILLION)
TABLE 311. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 312. G7 ENZYMES FOR DRUG SYNTHESIS MARKET SIZE, BY APPL

Companies Mentioned

The key companies profiled in this Enzymes for Drug Synthesis market report include:
  • AB Enzymes GmbH
  • ALLOYZMES Pte Ltd.
  • Amano Enzyme Inc.
  • BASF SE
  • Biomatter Inc.
  • Codexis, Inc.
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • GenScript Biotech Corporation
  • Lonza Group AG
  • Novozymes A/S
  • Promega Corporation
  • Royal DSM N.V.
  • Takara Bio Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.37 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.08 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Enzymes for Antibiotic Synthesis Market - Global Forecast 2026-2032 - Product Image

Enzymes for Antibiotic Synthesis Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Enzymes Market Size, Share, Trends and Forecast by Type, Source, Reaction Type, Application, and Region, 2025-2033 - Product Image

Enzymes Market Size, Share, Trends and Forecast by Type, Source, Reaction Type, Application, and Region, 2025-2033

  • Report
  • 140 Pages
  • Global
From
Enzymes for ß-lactam Antibiotics Market - Global Forecast 2026-2032 - Product Image

Enzymes for ß-lactam Antibiotics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Biocatalysis in Asymmetric Synthesis. Foundations and Frontiers in Enzymology - Product Image

Biocatalysis in Asymmetric Synthesis. Foundations and Frontiers in Enzymology

  • Book
Engineering Enzyme for Biosolution Global Market Insights 2026, Analysis and Forecast to 2031 - Product Image

Engineering Enzyme for Biosolution Global Market Insights 2026, Analysis and Forecast to 2031

  • Report
  • 84 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.